Is dr Paul van Diest, hoofd pathologie UMCU verantwoordelijk voor de medische fout bij Adrienne Cullen

Lees ook: bericht SIN-NL 13 april 2018
Geen openheid UMCU medische fout bij Adriennen Cullen. Waarom zwijgt de afdeling pathologie UMCU?

Vandaag publiceerde de NRC dat het UMCU een intern onderzoek gaat doen naar de oorzaak van het zoekraken van een laboratoriumuitslag waaruit bleek dat Adrienne Cullen (57) een voorstadium van kanker had.
Zij lijdt anno 2018 aan uitgezaaide baarmoederhalskanker.
Een eigen intern onderzoek door het UMCU betekent: zelfregulatie.
De zelfregulatie van de medische sector mbt medische fouten en de slachtofffers faalt al jaren, en alleen externe druk kan haar corrigeren, volgens Mr Johan Legemaate in 2006 , destijds al jaren topjurist van de artsenorganisatie KNMG. Als dank voor zijn niet aflatende steun aan  oa falende artsen werd hij hoogleraar in Amsterdam…..
Tot nu toe maakte het UMCU alleen de namen van Arie Franx hoogleraar gynaecologie en Huub van der Vaart gyneacoloog bekend. Zij hielden samen met Adrienne Cullen een opzienbarende lezing op 13 april 2018 in het UMCU en gaven blijk van openheid. Dit konden zij ook doen want zij hadden niets te vrezen, het UMCU had al 500.000 euro aan Adrienne Cullen betaald.
Maar het bleef stil van de zijde van de afdeling pathologie van het UMCU. Ook de Raad van Bestuur en de Inspectie Gezondheidszorg, aanwezig bij de lezing, zwegen.
Zal het onderzoek dan eindelijk onthullen dat ook de afdeling pathologie een enorme fout maakte door het resultaat van het laboratoriumonderzoek waaruit bleek dat Adrienne een voorstadium van kanker had, kwijt te raken en niets te doen?????
Zal dan eindelijk het hoofd van de afdeling pathologie zijn verantwoordelijkheid nemen, door en excuses te maken aan Adrienne Cullen, op te stappen en zijn leven verder te wijden aan het verbeteren van patientveiligheid en de kwaliteit van zorg???
Het betreft: P. J. van Diest MD PhD., hoofd pathologie UMCU

—————————————-

http://tissuepathology.com/2016/05/27/dutch-pathology-department-among-the-first-in-the-world-to-go-digital/#axzz5n9YDiC7F

Dutch Pathology Department Among the First in the World to go Digital

| May 27, 2016

Recently heard Dr. Paul van Diest speak about their experience with digital pathology in a respectable-size department with 30,000 surgical pathology cases. In his talk he claimed “Just Do It” with regards to digital pathology implementation in a busy surgical pathology practice. Albeit, the regulatory issues and constraints in places such as the Netherlands provide a better practice milieu for large scale implementation for primary reads. 

Pathologists at University Hospital Utrecht (UMC Utrecht) in the Netherlands have become among the first in the world to review histology cases for primary diagnostics digitally. The completely paper- and glass slide-free pathology review workflow, enabled by Sectra Pathology PACS, provides the pathologists with access to both digital pathology and radiology images as well as patient information from a single workstation. This significantly increases workflow efficiency and enables enhanced collaboration between pathologists and radiologists at the hospital, which in turn reduces lead times and increases efficiency in cancer care.

Sectra Pathology PACS is tightly integrated both with the LIMS (Laboratory Information Management System) used at UMC Utrecht and with a pathology laboratory application (PALGA) within the nationwide network and registry of histopathology and cytopathology in the Netherlands. This enables full access to lab data, requests, patient information and digital pathology images, and allows the pathologists to work completely digitally when performing primary diagnostics, thereby increasing reading efficiency.

pvd

Professor Paul van Diest

“With the digitization of pathology and the use of it in primary diagnostics we are able to work in a more efficient way. The MDT meetings are prepared and supported with digital pathology images and, like with radiology in the past, by making the information simply available to other specialties we can collaborate in a better way and therefore improve the quality of the healthcare pathway for the patient,” says Professor Paul van Diest, head of the Pathology Department at UMC Utrecht.

Sectra’s pathology PACS builds on the same infrastructure as Sectra’s solution for handling radiology images (Sectra radiology PACS), which is already used at the radiology department at UMC Utrecht. This enables in-depth cooperation between radiologists and pathologists, two of the key functions in effective cancer care. For example, with joint access to radiology and pathology images, the hospital’s multidisciplinary rounds have become more effective.

The pathology department at UMC Utrecht employs about 14 pathologists and 14 residents, and handles approximately 30,000 histopathological and 300 autopsy requests per year. Almost all of the histopathological slides, about 200,000 slides per year, are scanned and stored digitally.

Digitization of primary diagnostics in pathology to benefit cancer care

Sectra provides a complete solution for primary diagnostics. The solution includes archiving and storage solutions together with high-end review workstations. It allows pathologists to make their diagnoses and reports with higher precision and less time spent per case. Sectra’s solution for digital pathology is built on the same platform as the company’s radiology PACS, the solution for managing radiology images. With a shared technical platform, images from both of the diagnostic specialties can be stored and displayed in a single system. This enables deeper cooperation between radiologists and pathologists and facilitates, for example, multidisciplinary rounds, which is a step in integrated diagnostics.

Although European pathology departments are in the process of digitizing their work, only a few hospitals have implemented full-scale digital pathology solutions. In the US, digital pathology for primary diagnostics is still pending FDA approval.

About Sectra

The world needs more efficient healthcare and more secure communication. Sectra plays a key role in meeting these needs. Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. The company was founded in 1978, has its head office in Linköping, Sweden, with subsidiaries in 14 countries, and operates through partners worldwide. Sales in the 2014/2015 fiscal year totaled SEK 961 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit www.sectra.com

In the medical market, Sectra develops and sells IT solutions for the management and communication of all types of medical images – primarily in radiology, mammography, pathology and orthopaedics, as well as other departments where medical images are used. Sectra has a strategic focus on making cancer care more efficient. More than 1,700 hospitals, clinics and imaging centers worldwide use Sectra’s systems daily. This makes Sectra one of the world’s leading providers of IT solutions for managing medical images and patient information. The company commands a market-leading position in Sweden, Norway, the Netherlands and Portugal, holds a prominent position in the UK and is growing in the US. Sectra has delivered some of the largest installations of medical IT systems worldwide and its systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East.

Source: Cision (http://news.cision.com)